Reproductive aging, sex steroids, and mood disorders

Harvard Review of Psychiatry

Volumn 17, Issue 2, 2009, Pages 87-102

  Harsh, Veronica ^a   Meltzer Brody, Samantha ^b   Rubinow, David R ^b   Schmidt, Peter J ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Depression; Estrogen; Menopause transition

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; PRASTERONE; SEX HORMONE; TESTOSTERONE;

AGING; ANXIETY DISORDER; CLIMACTERIUM; DEPRESSION; DYSPHORIA; FEMALE; GENITAL SYSTEM; HORMONE BLOOD LEVEL; HORMONE RELEASE; HOT FLUSH; HUMAN; LONGITUDINAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENTAL HEALTH; MOOD DISORDER; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SOCIAL SUPPORT; STEROID RELEASE; WOMEN'S HEALTH; DRUG EFFECT; ESTROGEN THERAPY; MAJOR DEPRESSION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREMENOPAUSE; PREVALENCE; PSYCHOLOGICAL ASPECT;

AGING; DEPRESSIVE DISORDER, MAJOR; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GONADAL HORMONES; HUMANS; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE;

EID: 68549110341     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1080/10673220902891877     Document Type: Review

References (178)

1. Bevan Lewis W. A text-book of mental diseases: with special reference to the pathological aspects of insanity. London: Grif- fin, 1899.
2. Conklin WJ. Some neuroses of the menopause. Trans Am Assoc Obstet Gynecol 1889;2:301-311
3. Maudsley H. The physiology and pathology of the mind. New York: Appleton, 1867.
4. Kraepelin E. Psychiatrie: ein Lehrbuch fur Studierende und̈ Arrzte. Leipzig: Barth, 1909.
5. Bleuler E. Textbook of psychiatry.New York: Macmillan, 1924.
6. Stenstedt A. Involutionalmelancholia: an etiologic clinical and social study of endogenous depression in later life, with special special reference to genetic factors. Acta Psychiatr Neurol Scand 1959;127:1-71.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 1st ed. Washington, DC: APA, 1952.
8. Werner AA, Johns GA, Hoctor EF, Ault CC, Kohler LW, Weis MW. Involutional melancholia: probable etiology and treatment. JAMA 1934;103:13-16
9. Rosenthal S. The involutional depressive syndrome.AmJ Psychiatry 1968;124:21-35.
10. Weissman MM. The myth of involutional melancholia. JAMA 1979;242:742-744
11. Winokur G. Depression in the menopause. Am J Psychiatry 1973;130:92-93
12. Myers JK,Weissman MM, Tischler GL, et al. Six-month prevalence of psychiatric disorders in three communities. Arch Gen Psychiatry 1984;41:959-967
13. Brown RP, Sweeney J, Loutsch E, Kocsis J, Frances A. Involutional melancholia revisited. Am J Psychiatry 1984;141: 24-28
14. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874-878 (Pubitemid 33031310)
15. Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996;81:1495-1501.
16. Treloar AE. Menstrual cyclicity and the pre-menopause. Maturitas 1981;3:249-264
17. Richardson SJ. The biological basis of the menopause. Baillieres Clin Endocrinol Metab 1993;7:1-16.
18. Miro F, Parker SW, Aspinall LJ, Coley J, Perry PW, Ellis JE. Relationship between follicle-stimulating hormone levels at the beginning of the human menstrual cycle, length of the follicular phase and excreted estrogens: the FREEDOM study. J Clin Endocrinol Metab 2004;89:3270-3275
19. Klein NA, Harper AJ, Houmard BS, Sluss PM, Soules MR. Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development? J Clin Endocrinol Metab 2002;87:5746-5750
20. Hall JE. Neuroendocrine changes with reproductive aging in women. Semin Reprod Med 2007;25:344-351
21. Hall JE. Neuroendocrine physiology of the early and late menopause. Endocrinol Metab Clin North Am 2004;33: 637-659
22. Welt CK, Jimenez Y, Sluss PM, Smith PC, Hall JE. Control of estradiol secretion in reproductive ageing. Hum Reprod 2006;21:2189-2193
23. Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 1995;80:3537-3545
24. Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM, Fraser IS. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the staging of reproductive aging workshop (STRAW) staging system. J Clin Endocrinol Metab 2007;92:3060-3067
25. Freeman EW, Sammel MD, Gracia CR, et al. Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril 2005;83:383-392
26. Couzinet B, Meduri G, Lecce MG, et al. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab 2001;86:5060-5066
27. Davison SL, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-3853
28. Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 2007;92:3040-3043 (Pubitemid 47236368)
29. Chen J, Sowers MR, Moran FM, et al. Circulating bioactive androgens in midlife women. J Clin Endocrinol Metab 2006;91:4387-4394
30. Kaufert PA, Gilbert P, Tate R. Defining menopausal status: the impact of longitudinal data. Maturitas 1987;9:217-226
31. Guthrie J, Dennerstein L, Burger H. How reliably does 12- month amenorrhea define final menstrual period? Data from a longitudinal study. Climacteric 2002;5:92.
32. Harlow SD, Cain K, Crawford S, et al. Evaluation of four proposed bleeding criteria for the onset of late menopausal transition. J Clin Endocrinol Metab 2006;91:3432-3438
33. Ferrell RJ, Simon JA, Pincus SM, et al. The length of perimenopausal menstrual cycles increases later and to a greater degree than previously reported. Fertil Steril 2006;86:619-624
34. Randolph JFJr, Crawford S, Dennerstein L, et al. The value of follicle-stimulating hormone concentration and clinical findings as markers of the late menopausal transition. J Clin Endocrinol Metab 2006;91:3034-3040
35. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA, 1994.
36. Spitzer RL,Williams JB, GibbonM, First MB. Structured clinical interview for DSM-III-R. Patient edition. New York: Biometrics Research Department, New York State Psychiatric Institute, 1990.
37. Spijker J, de Graaf R, Bijl RV, Beekman ATF, Ormel J, Nolen WA. Duration of major depressive episodes in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry 2002;181:208-213
38. Roberts RE, Vernon SW. The center for epidemiologic studies depression scale: its use in a community sample. Am J Psychiatry 1983;140:41-46
39. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Agency for Healthcare Research and Quality, 2005. http:// www.ahrq.gov/downloads/pub/evidence/pdf/ peridepr/peridep. pdf
40. Weissman MM, Leaf PJ, Tischler GL, et al. Affective disorders in five United States communities. Psychol Med 1988;18:141-153
41. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey I: lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85-96.
42. McKinlay JB, McKinlay SM, Brambilla D. The relative contributions of endocrine changes and social circumstances to depression in mid-aged women. J Health Soc Behav 1987;28:345-363
43. Kaufert PA, Gilbert P, Tate R. The Manitoba project: a reexamination of the link between menopause and depression. Maturitas 1992;14:143-155
44. Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women's Health Study. Ann Epidemiol 1994;4:214-220
45. Matthews KA, Wing RR, Kuller LH, et al. Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J Consult Clin Psychol 1990;58:345-351
46. Holte A. Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women. Maturitas 1992;14:127-141
47. Fugate Woods N, Mariella A, Sullivan Mitchell E. Patterns of depressedmood across themenopausal transition: approaches to studying patterns in longitudinal data. Acta Obstet Gynecol Scand 2002;81:623-632
48. Maartens LW, Leusink GL, Knottnerus JA, Smeets CG, Pop VJ. Climacteric complaints in the community. Fam Pract 2001;18:189-194
49. Den Tonkelaar I, Broekmans FJ, De Boer EJ, et al. The stages of reproductive aging workshop. Menopause 2002;9:463-464
50. Hardy R, Kuh D. Change in psychological and vasomotor symptom reporting during the menopause. Soc Sci Med 2002;55:1975-1988
51. Dennerstein L, Lehert P, Burger H, Dudley E. Mood and the menopausal transition. J Nerv Ment Dis 1999;187:685-691
52. Hunter M. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 1992;14:117-126
53. O'Connor VM, Del Mar CB, Sheehan M, Siskind V, Fox-Young S, Cragg C. Do psycho-social factors contribute more to symptom reporting by middle-aged women than hormonal status? Maturitas 1995;20:63-69
54. Bromberger JT, Meyer PM, Kravitz HM, et al. Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health 2001;91:1435-1442
55. Maartens LWF, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas 2002;42:195-200.
56. Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol 2003;158:347-356
57. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70.
58. Stewart DE, Boydell K, Derzko C, Marshall V. Psychologic distress during the menopausal years in women attending a menopause clinic. Int J Psychiatry Med 1992;22:213-220
59. Dennerstein L, Smith AMA,Morse C, et al.Menopausal symptoms in Australian women. Med J Aust 1993;159:232-236
60. Hay AG, Bancroft J, Johnstone EC. Affective symptoms in women attending a menopause clinic. Br J Psychiatry 1994;164:513-516
61. Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994;272:1749-1756
62. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition. The Harvard study of moods and cycles. Arch Gen Psychiatry 2006;63:385-390
63. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375-382
64. Bromberger JT, Matthews KA, Schott LL, et al. Depressive symptoms during the menopausal transition: the study of women's health across the nation (SWAN). J Affect Disord 2007;103:267-272
65. Bromberger JT, Kravitz HM, Matthews KA, Youk A, Brown C, Feng W. Predictors of first episodes of clinical depression in midlife women. Abstract presented at the 160th annual meeting of the American Psychiatric Association, San Diego, CA, May 2007.
66. Schmidt PJ, Haq NA, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 2004;161:2238-2244
67. Steinberg EM, Rubinow DR, Bartko JJ, et al. A cross sectional evaluation of perimenopausal depression. J Clin Psychiatry 2008;69:973-980
68. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health 2006;96:1226-1235
69. Juang KD, Wang SJ, Lu SR, Lee SJ, Fuh JL. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas 2005;52:119-126
70. Freeman EW, Sammel MD, Grisso JA, Battistini M, Garcia- Espagna B, Hollander L. Hot flashes in the late reproductive years: risk factors for African American and Caucasian women. J Womens Health Gend Based Med 2001;10:67-76. (Pubitemid 32229475)
71. Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 2005;12:258-266
72. Appleby L, Montgomery J, Studd J. Oestrogens and affective disorders. In: Studd J, ed. Progress in obstetrics and gynaecology. Edinburgh: Churchill Livingstone, 1981:289-302.
73. Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000;183:414-420
74. Soares CD, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebocontrolled trial. Arch Gen Psychiatry 2001;58:529-534
75. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 2004;55:406-412
76. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998;279:688-695
77. LeBlanc ES, Janowsky J, Chan BKS, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001;285:1489-1499
78. Hogervorst E, Yaffe K, Richards M, Huppert F. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev 2002;(3):CD003122.
79. Gibbs RB. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 2000;21:107-116
80. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study. JAMA 2002;288:2123-2129
81. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 2002;288:2170-2172
82. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002;53:605-619
83. Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591-2602
84. Manson JE, Bassuk SS. Invited commentary: hormone therapy and risk of coronary heart disease-why renew the focus on the early years of menopause? Am J Epidemiol 2007;166:511-517
85. Hodis HN, Mack WJ. Postmenopausal hormone therapy in clinical perspective. Menopause 2007;14:944-957
86. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477
87. Rossouw JE, Anderson GL, Prentice RL, et al.; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333
88. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: theWomen's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662
89. Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med 2003;348:645-650 (Pubitemid 36204960)
90. Herrington DM, Howard TD, Hawkins GA, et al. Estrogenreceptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002;346:967-974
91. Yaffe K, Lui LY, Grady D, Stone K, Morin P. Estrogen receptor 1 polymorphism and risk of cognitive impairment in older women. Biol Psychiatry 2002;51:677-682
92. Woolley CS, Schwartzkroin PA. Hormonal effects on the brain. Epilepsia 1998;39:S2-S8.
93. McEwen BS. Basic neurobiology of ovarian steroids: clinical implications. Dial Clin Neurosci 2002;4:163-175
94. Rachman IM,Unnerstall JR, PfaffDW, Cohen RS. Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test. Proc Natl Acad Sci U S A 1998;95:13941-13946
95. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 1998;44:839-850
96. Pecins-Thompson M, Brown NA, Bethea CL. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res 1998;53:120-129
97. McQueen JK, Wilson H, Fink G. Estradiol-17ß increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Brain Res Mol Brain Res 1997;45:13-23.
98. Lu NZ, Eshleman AJ, Janowsky J, Bethea CL. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques.Mol Psychiatry 2003;8:353-360
99. ClarkeWP,Maayani S. Estrogen effects on 5-HT1A receptors in hippocampal membranes from ovariectomized rats: functional and binding studies. Brain Res 1990;518:287-291
100. Thomas ML, Bland DA, Clarke CH, Cunningham KA. Estrogen regulation of serotonin (5-HT) transporter and 5-HT1A receptor mRNA in female rat brain. Abstr Soc Neurosci 1997;23:1501.
101. Sumner BEH, Fink G. Estrogen increases the density of 5- hydroxytryptamine2A receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol 1995;54:15-20.
102. Maswood S, Truitt W, Hotema M, Caldarola-Pastuszka M, Uphouse L. Estrous cycle modulation of extracellular serotonin inmediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors. Brain Res 1999;831:146-154
103. Nestler EJ, Terwilliger RZ, Duman RS. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J Neurochem 1989;53:1644-1647
104. Duman RS, Heninger GR,Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597-606.
105. Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element-binding protein (CREB) in rat hippocampus. J Neurosci 1996;16:2365-2372
106. Rantamaki T, Hendolin P, Kankaanpaa A, et al. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase- Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 2007;32:2152-2162
107. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 2001;120:87-95.
108. Martinez-Turrillas R, Del Rio J, Frechilla D. Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment. Neuropharmacology 2005;49: 1178-1188
109. Kozisek ME, Middlemas D, Bylund DB. The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment. Neuropharmacology 2008;54:251-257
110. Sohrabji F, Greene LA, Miranda RC, Toran-Allerand CD. Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J Neurobiol 1994;25:974-988
111. Jezierski MK, Sohrabji F. Region- and peptide-specific regulation of the neurotrophins by estrogen. Mol Brain Res 2000;85:77-84.
112. Jezierski MK, Sohrabji F. Estrogen enhances retrograde transport of brain-derived neurotrophic factor in the rodent forebrain. Endocrinology 2003;144:5022-5029
113. Zhou Y, Watters JJ, Dorsa DM. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 1996;137:2163-2166
114. Murphy DD, Cole NB, Segal M. Brain-derived neurotrophic factor mediates estradiol-induced dendritic spine formation in hippocampal neurons. Proc Natl Acad Sci U S A 1998;95:11412-11417
115. Antonijevic IA, Stalla GK, Steiger A. Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol 2000;182: 277-282
116. Wilkie MJV, Smith D, Reid IC, et al. A splice site polymorphism in the G-protein â subunit influences antidepressant efficacy in depression. Pharmacogenet Genomics 2007;17:207-215
117. Prossnitz ER, Sklar LA, Oprea TI, Arterburn JB. GPR30: a novel therapeutic target in estrogen-related disease. Trends Pharmacol Sci 2008;29:116-123
118. Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 2005;19:1951-1959
119. Kelly MJ, Wagner EJ. Estrogen modulation of G-proteincoupled receptors. Trends Endocrinol Metab 1999;10:369-374
120. Steingold KA, Laufer L, Chetkowski RJ, et al. Treatment of hot flashes with transdermal estradiol administration. J Clin Endocrinol Metab 1985;61:627-632
121. Brincat M, Studd JWW, O'Dowd T, et al. Subcutaneous hormone implants for the control of climacteric symptoms: a prospective study. Lancet 1984;323:16-18
122. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-995
123. Sherwin BB, Gelfand MM. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985;151:153-160
124. Brambilla F, Maggioni M, Ferrari E, Scarone S, Catalano M. Tonic and dynamic gonadotropin secretion in depressive and normothymic phases of affective disorders. Psychiatry Res 1990;32:229-239
125. Amsterdam JD,Winokur A, Lucki I, Snyder P. Neuroendocrine regulation in depressed postmenopausal women and healthy subjects. Acta Psychiatr Scand 1983;67:43-49
126. Altman N, Sachar EJ, Gruen PH, Halpern FS, Eto S. Reduced plasma LH concentration in postmenopausal depressed women. Psychosom Med 1975;37:274-276
127. Guicheney P, Ĺeger D, Barrat J, et al. Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms. Eur J Clin Invest 1988;18:297-304.
128. Ballinger S. Stress as a factor in lowered estrogen-levels in the early postmenopause. Ann N Y Acad Sci 1990;592:95-113.
129. Huerta R, Mena A, Malacara JM, Diaz de Leon J. Symptoms at perimenopausal period: its association with attitudes toward sexuality, life-style, family function, and FSH levels. Psychoneuroendocrinology 1995;20:135-148
130. Saletu B, Brandstatter N, Metka M, et al. Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls. Maturitas 1996;23:91-105.
131. Barrett-Connor E, von Muhlen D, Laughlin GA, Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo study. J Am Geriatr Soc 1999;47:685-691
132. Cawood EH, Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. PsycholMed 1996;26:925-936
133. Schmidt PJ, Murphy JH, Haq N, Danaceau MA, Simpson St.Clair L. Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology 2002;27:907-920
134. Matthews KA. Myths and realities of the menopause. Psychosom Med 1992;54:1-9.
135. Majewska MD, Demirgoren S, Spivak CE, London ED. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res 1990;526:143-146
136. Baulieu E-E, Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci U S A 1998;95:4089-4091
137. Zwain IH, Yen SSC. Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology 1999;140:880-887
138. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-1367
139. Wolkowitz OM, Reus VI, Keebler A, et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 1999;156:646-649
140. BlochM, Schmidt PJ, DanaceauMA, Adams LF, Rubinow DR. Dehydroepiandrosterone treatment of mid-life dysthymia. Biol Psychiatry 1999;45:1533-1541
141. Schmidt PJ, Daly RC, Bloch M, et al. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 2005;62:154-162
142. Wolf OT, Neumann O, Hellhammer DH, et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 1997;82:2363-2367
143. Laughlin GA, Barrett-Connor E. Sexual dimorphism in the in- fluence of advanced aging on adrenal hormone levels: the Rancho Bernardo study. J Clin Endocrinol Metab 2000;85:3561-3568
144. Ferrari E, LocatelliM, Arcaini A, et al. Chronobiological study of some neuroendocrine features of major depression in elderly people. Abstract presented at the 79th annual meeting of the Endocrine Society, Minneapolis, MN, June 1997.
145. Daly RC, Danaceau MA, Rubinow DR, Schmidt PJ. Concordant restoration of ovarian function and mood in perimenopausal depression. Am J Psychiatry 2003;160:1842-1846
146. Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189-212.
147. Montgomery JC, Brincat M, Tapp A, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987;329:297-299
148. Saletu B, Brandstatter N, Metka M, et al. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacology 1995;122:321-329
149. Spitzer RL, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders: results from the PRIME-MD 1000 study. JAMA 1995;274:1511-1517
150. Jaszmann L, van Lith ND, Zaat JCA. The perimenopausal symptoms: the statistical analysis of a survey Part A. Med Gynaecol Sociol 1969;4:268-277
151. Joffe H, Hall JE, Soares CN, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392-398
152. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-358
153. Schiff I, Regestein Q, Tulchinsky D, Ryan KJ. Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA 1979;242:2405-2407
154. Owens JF,MatthewsKA. Sleep disturbance in healthymiddleaged women. Maturitas 1998;30:41-50.
155. Polo-Kantola P, Saaresranta T, Polo O. Aetiology and treatment of sleep disturbances during perimenopause and postmenopause. CNS Drugs 2001;15:445-452
156. Polo-Kantola P, Erkkola R, Helenius H, Irjala K, Polo O. When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol 1998;178:1002-1009
157. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton- Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19-28.
158. Ohayon MM. Severe hot flashes are associated with chronic insomnia. Arch Intern Med 2006;166:1262-1268
159. Freedman RR, Roehrs TA. Effects of REM sleep and ambient temperature on hot flash-induced sleep disturbance. Menopause 2006;13:576-583
160. Freedman RR, Roehrs TA. Lack of sleep disturbance from menopausal hot flashes. Fertil Steril 2004;82:138-144
161. Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 2007;30:873-880
162. Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 2007;30:274-280
163. Kahn-Greene ET, Killgore DB, Kamimori GH, Balkin TJ, Killgore WDS. The effects of sleep deprivation on symptoms of psychopathology in healthy adults. Sleep Med 2007;8:215-221
164. Freedman RR, Roehrs TA. Sleep disturbance in menopause. Menopause 2007;14:826-829
165. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345-356
166. Cooke DJ, Greene JG. Types of life events in relation to symptoms at the climacterium. J Psychosom Res 1981;25:5-11.
167. Dennerstein L, Lehert P, Dudley E, Guthrie J. Factors contributing to positive mood during the menopausal transition. J Nerv Ment Dis 2001;189:84-89
168. Greene JG, Cooke DJ. Life stress and symptoms at the climacterium. Br J Psychiatry 1980;136:486-491
169. Ballinger S, Cobbin D, Krivanek J, Saunders D. Life stresses and depression in the menopause. Maturitas 1979;1: 191-199
170. Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle midlife women's health study. Maturitas 1996;25:1-10.
171. Woods NF, Mitchell ES. Pathways to depressed mood for midlife women: observations from the Seattle midlife women's health study. Res Nurs Health 1997;20:119-129
172. Schmidt PJ, Murphy JH, Haq NA, Rubinow DR, Danaceau M. Stressful life events, personal losses, and perimenopauserelated depression. Arch Womens Ment Health 2004;7:19-26.
173. Dennerstein L, Dudley E, Guthrie J. Empty nest or revolving door? A prospective study of women's quality of life in midlife during the phase of children leaving and re-entering the home. Psychol Med 2002;32:545-550
174. Kendler KS, Kessler RC, Walters EE, et al. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 1995;152:833-842
175. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:291-293
176. Maciejewski PK, Prigerson HG, Mazure CM. Sex differences in event-related risk for major depression. Psychol Med 2001;31:593-604.
177. Seeman TE, Crimmins E. Social environment effects on health and aging: integrating epidemiologic and demographic approaches and perspectives. Ann N Y Acad Sci 2001;954:88-117.
178. Erikson EH. Eight ages of man. Int J Psychiatry 1966;2:281-307.